The dynamic equilibrium between ATP synthesis and ATP consumption is lower in isolated mitochondria from myotubes established from type 2 diabetic subjects compared to lean control

Biochemical and Biophysical Research Communications

Volumn 409, Issue 4, 2011, Pages 591-595

  Minet, Ariane D ^a   Gaster, Michael ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

ATP; Equilibrium; Human skeletal muscle; Mitochondria; Myotubes

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ADENOSINE TRIPHOSPHATE; BETA ACTIN; GLUCOSE; HEMOGLOBIN A1C; HEXOKINASE; INSULIN; METHYLCROTONOYL COENZYME A CARBOXYLASE; MITOFUSIN 2; PROHIBITIN; PROPIONYL COENZYME A CARBOXYLASE; PROTEIN P21; PYRUVATE CARBOXYLASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC OBESITY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; MALE; MITOCHONDRION; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE METABOLISM; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEX DIFFERENCE; SKELETAL MUSCLE;

ADENOSINE TRIPHOSPHATE; DIABETES MELLITUS, TYPE 2; FEMALE; HEXOKINASE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE FIBERS, SKELETAL; OBESITY; THINNESS;

EID: 79959214859     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.028     Document Type: Article

References (31)

1. Ritov V.B., Menshikova E.V., He J., Ferrell R.E., Goodpaster B.H., Kelley D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005, 54:8-14.
2. Boushel R., Gnaiger E., Schjerling P., Skovbro M., Kraunsoe R., Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007, 50:790-796.
3. Mogensen M., Sahlin K., Fernstrom M., Glintborg D., Vind B.F., Beck-Nielsen H., Hojlund K. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007, 56:1592-1599.
4. Hey-Mogensen M., Hojlund K., Vind B.F., Wang L., Dela F., Beck-Nielsen H., Fernstrom M., Sahlin K. Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes. Diabetologia 2010, 53:1976-1985.
5. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 2004, 350:664-671.
6. Befroy D.E., Petersen K.F., Dufour S., Mason G.F., de Graaf R.A., Rothman D.L., Shulman G.I. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 2007, 56:1376-1381.
7. Minet A.D., Gaster M. ATP synthesis is impaired in isolated mitochondria from myotubes established from type 2 diabetic subjects. Biochem. Biophys. Res. Commun. 2010, 402:70-74.
8. Henry R.R., Ciaraldi T.P., Mudaliar S., Abrams L., Nikoulina S.E. Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels. Diabetes 1996, 45:400-407.
9. Gaster M., Petersen I., Hojlund K., Poulsen P., Beck-Nielsen H. The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 2002, 51:921-927.
10. Gaster M., Rustan A.C., Aas V., Beck-Nielsen H. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 2004, 53:542-548.
11. Gaster M., Rustan A.C., Beck-Nielsen H. Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes. Diabetes 2005, 54:648-656.
12. Frederiksen C.M., Hojlund K., Hansen L., Oakeley E.J., Hemmings B., Abdallah B.M., Brusgaard K., Beck-Nielsen H., Gaster M. Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia 2008, 51:2068-2077.
13. Gaster M. Reduced TCA flux in diabetic myotubes: a governing influence on the diabetic phenotype?. Biochem. Biophys. Res. Commun. 2009, 387:651-655.
14. Gaster M., Kristensen S.R., Beck-Nielsen H., Schroder H.D. A cellular model system of differentiated human myotubes. APMIS 2001, 109:735-744.
15. Ortenblad N., Mogensen M., Petersen I., Hojlund K., Levin K., Sahlin K., Beck-Nielsen H., Gaster M. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect. Biochim. Biophys. Acta 2005, 1741:206-214.
16. Wensaas A.J., Rustan A.C., Just M., Berge R.K., Drevon C.A., Gaster M. Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of beta-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid. Diabetes 2009, 58:527-535.
17. Gaster M. Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects. Biochem. Biophys. Res. Commun. 2009, 382:766-770.
18. Gaster M., Beck-Nielsen H. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects. Biochim. Biophys. Acta 2006, 1761:100-110.
19. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51:2944-2950.
20. Hornig-Do H.T., Gunther G., Bust M., Lehnartz P., Bosio A., Wiesner R.J. Isolation of functional pure mitochondria by superparamagnetic microbeads. Anal. Biochem. 2009, 389:1-5.
21. Gaster M. Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes. Biochim. Biophys. Acta 2007, 1772:755-765.
22. Shoshan-Barmatz V., De P., Zweckstetter V.M., Raviv Z., Keinan N., Arbel N. VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol. Aspects Med. 2010, 31:227-285.
23. Henry R.R., Abrams L., Nikoulina S., Ciaraldi T.P. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes 1995, 44:936-946.
24. Gaster M., Beck-Nielsen H. The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin-evidence from cultured myotubes. Biochim. Biophys. Acta 2004, 1690:85-91.
25. Gaster M. Mitochondrial mass is inversely correlated to complete lipid oxidation in human myotubes. Biochem. Biophys. Res. Commun. 2011, 404:1023-1028.
26. Schrauwen-Hinderling V.B., Kooi M.E., Hesselink M.K., Jeneson J.A., Backes W.H., van Echteld C.J., van Engelshoven J.M., Mensink M., Schrauwen P. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 2007, 50:113-120.
27. Hojlund K., Yi Z., Lefort N., Langlais P., Bowen B., Levin K., Beck-Nielsen H., Mandarino L.J. Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle. Diabetologia 2010, 53:541-551.
28. Karakelides H., Irving B.A., Short K.R., O'Brien P., Nair K.S. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes 2010, 59:89-97.
29. Boldogh I.R., Pon L.A. Interactions of mitochondria with the actin cytoskeleton. Biochim. Biophys. Acta 2006, 1763:450-462.
30. Csordas G., Renken C., Varnai P., Walter L., Weaver D., Buttle K.F., Balla T., Mannella C.A., Hajnoczky G. Structural and functional features and significance of the physical linkage between ER and mitochondria. J. Cell Biol. 2006, 174:915-921.
31. Boncompagni S., Rossi A.E., Micaroni M., Beznoussenko G.V., Polishchuk R.S., Dirksen R.T., Protasi F. Mitochondria are linked to calcium stores in striated muscle by developmentally regulated tethering structures. Mol. Biol. Cell 2009, 20:1058-1067.